Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users

Forensic Science International

Volumn 89, Issue 1-2, 1997, Pages 111-128

  Rothe, Michael ^a   Pragst, Fritz ^a   Spiegel, Katharina ^a   Harrach, Tibor ^a   Fischer, Kay ^a   Kunkel, Jürgen ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

3,4 methylenedioxyamphetamine derivatives in hair; Amphetamines in hair; Ecstasy; Ecstasy abuse history (self reported); Hair analysis

Indexed keywords

1 (1,3 BENZODIOXOL 5 YL) N METHYL 2 BUTANAMINE; 3,4 METHYLENEDIOXYAMPHETAMINE; ACID ANHYDRIDE; AMPHETAMINE; METHAMPHETAMINE;

ARTICLE; COLUMN CHROMATOGRAPHY; DERIVATIZATION; DRUG ABUSE; GAS CHROMATOGRAPHY; HAIR ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; SAMPLING; SELF REPORT; SWEAT; TABLET;

EID: 0030858309     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(97)00123-0     Document Type: Article

References (34)

1. W. Katzung, G. Harfst, Ecstasy, Synthetische Drogen vom XTC-Typ, ArtWare, Verlag und Medienagentur, Würzburg/Germany, 1996.
2. L. Hermle, M. Spitzer, D. Borchard, K.A. Kovar, E. Gouzoulis. Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?, Neuropsychopharmacology 8 (1993) 171-176.
3. T.D. Steele, U.D. McCann, G.A. Ricaurte, 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans. Addiction 89 (1994) 539-551.
4. E. Gouzoulis-Mayfrank, L. Hermle, K.-A. Kovar, H. Saß, Die Entactogene "Ecstasy" (MDMA), "Eve" (MDE) und andere ringsubstituierte Methamphetaminderivate, Nervenarzt 67 (1996) 369-380.
5. C. Brown, J. Osterloh, Multiple severe complications from recreational ingestion of MDMA ("Ecstasy"), J. Am. Med. Assoc. 258 (1987) 780-781.
6. I.S. Chadwick, P.D. Curry, A. Linsley, A.J. Freemont, B. Doren, Ecstasy, 3,4-metylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hypothermia, J. R. Soc. Med. 84 (1991) 371.
7. V. Fineschi, A. Masti, Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int. J. Legal Med. 108 (1996) 272-275.
8. G.R. Screaton, M. Singer, H.S. Cairns, A. Thrasher, M. Sarner, S.L. Cohen, Hyperpyrexia and rhabdomyolysis after MDMA ("Ecstasy") abuse, Lancet 339 (1992) 667-668.
9. P.J. Barret, G.T. Taylor, "Ecstasy" ingestion: a case report of severe complications, J. R. Soc. Med. 86 (1993) 233-234.
10. I.H. Fahal, D.F. Sallomi, M. Yaqoob, G.M. Bell, Acute renal failure after ecstasy, Br. Med. J. 305 (1992) 29.
11. C.M. Milroy, J.C. Clark, A.R.W. Forrest, Pathology of death associated with "Ecstasy" and "Eve" misuse, J. Clin. Pathol. 49 (1996) 149-153.
12. G. Skopp, R. Aderjan, J. Koster, Haaranalyse zur Diagnose toxischer Hepatitiden nach Mißbrauch von Ecstasy, Dtsch. med. Wschr. 120 (1995) 1165-1168.
13. G.P. Dowling, E.T. McDonough III, R.O. Bost, Eve and Ecstasy, a report of five deaths associated with the use of MDEA and MDMA, J. Am. Med. Assoc. 257 (1987) 1615-1617.
14. J.C. Hughes, M. McCabe, R.J. Evans, Intracranial haemorrhage associated with the ingestion of ecstasy. Arch. Emergency Med. 10 (1993) 372-374.
15. C.J. Schmidt, Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of ist N-desmethyl and N-ethyl analogs, Eur. J. Pharmacol. 136 (1987) 81-88.
16. U.D. McCann, A. Ridenour, Y. Shaham, G.A. Ricaurte, Serotonine neurotoxicity after (±)-3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"): a controlled study in humans, Neuropharmacology 10 (1994) 129-138.
17. S. Iwersen, A. Schmoldt, Drogentodesfälle durch MDMA und MDEA, in: T. Daldrup, F. Mußhoff (Eds.), Drogen und Arzneimittel im Straßenverkehr, Verlag Dr. Dieter Helm, Heppenheim, 1995, pp. 96-100.
18. U.D. McCann, G.A. Ricaurte, MDMA ("ecstasy") and panic disorder: induction by a single dose, Biol. Psychiatry 32 (1992) 950-953.
19. E. Gouzoulis, D. Borchardt, L. Hermle, A case of toxic psychosis induced by "eve" (3,4-methylenddioxyethamphetamine), Arch. Gen. Psychiatry 50 (1993) 75.
20. P. McGuire, T. Fahy, Chronic paranoid psychosis after misuse of MDMA ("ecstasy"), Br. Med. J. 302 (1991) 697.
21. J. Röhrich, G. Kauert, Determination of amphetamine and methylenedioxyamphetamine derivatives in hair. Forensic Sci. Int. 84 (1997) 179.
22. W. Weinmann, M. Bohnert, Letal Intoxication by methylenedioxyethamphetamine (MDEA). Forensic Sci. Int., submitted for publication.
23. P. Kintz, A. Tracqui, P. Mangin, Detection of drugs in human hair for clinical and forensic applications, Int. J. Leg. Med. 105 (1992) 1-4.
24. Y. Nakahara, K. Takahashi, Y. Takeda, K. Konuma, S. Fukui, T. Tokui, Hair analysis for drugs of abuse part II. Hair analysis for monitoring of methamphetamine abuse by isotope dilution gas chromatography/mass spectrometry. Forensic Sci. Int. 46 (1990) 243-254.
25. S. Suzuki, T. Inoue, H. Hori, S. Inayama, Analysis of methamphetamine in hair, nail, sweat and saliva by mass fragmentography, J. Anal. Toxicol. 13 (1989) 176-178.
26. H.H. Maurer, On the metabolism and toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry, Ther. Drug Monit. 18 (1996) 465-470.
27. H.K. Ensslin, K.-A. Kovar, H. Maurer, Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites by gas chromatography-mass spectrometry and fluorescence polarization immunoassay, J. Chromatogr. B 683 (1996) 189-197.
28. E.M. Thurman, M.J. Pedersen, R.L. Stout, T. Martin, Distinguishing sympathomimetic amines from amphetamine and methamphetamine in urin by gas chromatography/mass spectrometry, J. Anal. Toxicol. 16 (1992) 19-27.
29. G. Rochholz, Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine and methylenedioxyethamphetamine - a simple method applicable to biological fluides and hair. Int. J. Legal Med., submitted for publication.
30. G.W. Kunsman, B. Levine, J.J. Kuhlman, R.L. Jones, R.O. Hughes, C.I. Fujiyama, M.L. Smith, MDA-MDMA concentrations in urine specimens, J. Anal. Toxicol. 20 (1996) 517-521.
31. J.F. Wilsen, S. Green, F.D.J. Dunstan, C. Brewer, N. Perfect, Relationship between metadone dose, methadone hair concentration and hair colour in man, Ther. Drug Monit. 17 (1995) 419.
32. M.S. Slawson, D.G. Wilkins, R.L. Foltz, D.E. Rollins, Quantitative determination of phencyclidine in pigmented and nonpigmented hair by ion trap mass spectrometry, J. Anal. Toxicol. 20 (1996) 350-354.
33. M. Rothe, F. Pragst, S. Thor, J. Hunger, Effect of pigmentation on the drug deposition in hair of grey-haired subjects. Forensic Sci. Int., in press.
34. L. Poetsch, G. Skopp, H.P. Eser, M.R. Moeller, Zum Suchtmittelnachweis in Kopfhaaren. I. Die Abschätzung und Bedeutung des individuellen Haarwachstumsfensters und des interdermalen Abschnittes anagener Haare bei der segmentweisen Haaranalyse, Rechtsmedizin 6 (1996) 156-160.